⬆
X
By continuing to use the site, you allow the use of Cookies and agree to the privacy policy.
.,о.,р..и.:г,.и.,н.;н.,а;,л.. .,н.:а,.х.,о.,д.;и.,т..с.:я,, ..н.;а., .,k;,i..b.:e,;r.,i.,s.,.;.r.:u,

D43.7 neoplasm of uncertain or unknown behaviour, other parts of central nervous system

Add
Found partially in the 19 (13) ⓘXFound partially in the 19 drugs (13 of these, according to Kiberis statistics) in 23 selected books (authors) HomeopathyX
  Effect Influence Cases ⓘ X Effect - how much the symptom improves in one treatment cycle on average. Example: drug Pain relief for cancer pain-Effectiveness (E) is high, but the effect (I) negative, because the patient will get worse over time.
Influence of the symptom on the outcome of the patient's treatment as a whole (i.e., the importance of the symptom). Example: menopause can not be cured (E low). But some means during menopause will be better than others (I high).
Cases - the number of investigated treatment results for a given complaint, on the basis of which the effect and effect were calculated. These cases have already passed automatic AI verification of data quality and reliability.
  • d43.7 neoplasm of uncertain or unknown behaviour, other parts of central nervous system
  •  34%-14%20 read Hydrastis canadensis
    Oncology - E 34% (I -14%, 20 cases.); Central nervous system - E 38% (I -1%, 10 cases.)
  •  30%+2%71 read Silica terra
    Oncology - E 30% (I 2%, 71 cases.); Central nervous system - E 45% (I 5%, 78 cases.)
  •  30%-7%6 read Cundurango
  •  28%+7%52 read Conium maculatum
    Oncology - E 28% (I 7%, 52 cases.); Central nervous system - E 56% (I 9%, 52 cases.)
  •  27%-2%15 read Apis mellifica
    Oncology - E 27% (I -2%, 15 cases.); Central nervous system - E 49% (I -6%, 15 cases.)
  •  26%+2%4 read Aurum muriaticum
    Oncology - E 26% (I 2%, 4 cases.); Central nervous system - E 52% (I 21%, 4 cases.)
  •  23%+1%8 read Phytolacca decandra
    Oncology - E 23% (I 1%, 8 cases.); Central nervous system - E 28% (I 0%, 9 cases.)
  •  20%-10%6 read Glonoinum
    Oncology - E 20% (I -10%, 6 cases.); Central nervous system - E 45% (I 8%, 9 cases.)
  •  14%-8%8 read Spigelia anthelmia
    Oncology - E 14% (I -8%, 8 cases.); Central nervous system - E 30% (I -3%, 24 cases.)
  •  13%-2%103 read Lachesis muta
    Oncology - E 13% (I -2%, 103 cases.); Central nervous system - E 36% (I 4%, 183 cases.)
  •  11%-1%70 read Calcarea carbonica
    Oncology - E 11% (I -1%, 70 cases.); Central nervous system - E 37% (I 4%, 127 cases.)
  •  6%-34%23 read Crotalus horridus
    Oncology - E 6% (I -34%, 23 cases.); Central nervous system - E 32% (I -6%, 36 cases.)
  •  -1%-20%5 read Carbo animalis
  •  Asterias rubens read
  •  Galium aparine read
  •  Kali cyanatum read
  •  Murex purpurea read
  •  Sulfonalum read
  •  Viburnum prunifolium read